DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Tisopurine
Tisopurine
(12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al
Classification of Medicinal Drugs and Driving: Co-Ordination and Synthesis Report
Alternatives to Allopurinol Hyper-Responsiveness to EBV In
General Pharmacology
Alphabetical Listing of ATC Drugs & Codes
(12) Patent Application Publication (10) Pub. No.: US 2002/0102215 A1 100 Ol
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
(12) United States Patent (10) Patent No.: US 8,158,152 B2 Palepu (45) Date of Patent: Apr
(Indol-5-Yl)Thiazolederivatives As Xanthine Oxidase(XO)Inhibitors
HLA Antigens Dw4 and Dw14 in Rheumatoid Arthritis
Alternatives to Allopurinol Hyper-Responsiveness to EBV In
CHAPTER-IV an Improved Process for Synthesis of Febuxostat Which Is an Inhibitor of Xanthine Oxidase
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
Management of Hyperuricemia & Gouty Arthritis with Unani Murakkab
Cross-Sectional Analysis of Nutrition and Serum Uric Acid
International Journal of Medical and Health Sciences
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Weird Thyroid Function Tests, Difficult Gout, and Dementia
Top View
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Atc Index 2010
Atc Index 2009
Bicyclic-Fused Heteroaryl Or Aryl Compounds and Their
Pharmaabkommen A1 E
Customs Tariff - Schedule Xxi - 1
I Ha Un Torn Datuk Umum Mundial Month
Effects of the Concomitant Administration of Xanthine Oxidase
Hologram Based QSAR Analysis of Xanthine Oxidase Inhibitors
Topomer Comfa Analysis of Xanthine Oxidase Inhibitors
WO 2015/150995 Al 8 October 2015 (08.10.2015) P O P C T
JIA Guideline Appendix 4
Pharmaco Sensor Jane Doe N8C9841 COVER LETTER
(12) United States Patent (10) Patent No.: US 9,023,856 B2 Roberts Et Al
(12) United States Patent (10) Patent No.: US 6,680,047 B2 Klaveness Et Al
(12) United States Patent (10) Patent No.: US 9,642,809 B2 Hemmingsen Et Al
Who Want a La Unitate Un Man At
Role of Vitamin C in Prophylaxis and Treatment of Gout—A Literature Review
Confidential: for Review Only
Supplementary Materials
Pharmaceutical Appendix to the Tariff Schedule 2
JIA Uveitis Guideline Appendix 3
Harmonized Tariff Schedule of the United States (2006) (Rev
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
Drug Repurposing to Identify Therapeutics Against COVID 19 with SARS-Cov- 2 Spike Glycoprotein and Main Protease As Targets: an in Silico Study
WO 2012/170676 Al 13 December 2012 (13.12.2012) P O P C T
Journal of Advanced Scientific Research a NEW VALIDATED
Agranulocytosis: an Adverse Effect of Allopurinol Treatment Agranulocitosi: Effetto Avverso Da Allopurinolo
Indication of Medication 1. Any Drug Prescribed Without an Evidence-Based Clinical Indication